The final Trump card / The Great Set-up
"looks like the whole thing's going to be brought down on top of them.
The whole diseased corrupt system.Is coming down. Around Them.
Nothing can stop this. Nothing.
What we're witnessing right now. Everything that you're seeing.
What makes a great movie?"
start @ 10.50 to save time:
Ep. 2376 - PANIC, What Makes A Good Movie, Great Act…
ditto-audio w action-packed video ;-)
'Trump takes about Big-Tech ...
Ep. 2377b - Checkmate, [Zero Day] Approaches, Sometimes A Good Movie Can Reveal A Lot Of Truth
Situation Update, Jan 14th, 2021 - The FEMA + Military coup to SAVE America, not destroy it
'The Amazing Information' starts at 8:40 minutes in:
RedPill78 @RedPill78 on GAB
Occam's Razor Today at 1pm est, let's do some news @M2Madness
You can watch Occam's Razor on the following platforms:
Hanita Zeltser Laven6 November 2020 ·Wake up America !!!!!!
Republicide! Jeffrey Prather. 1:03:26
Atom Wrote: PSA - ive listened to this guy prior........ seems solid........deep diver
How to report a COVID-19 vaccine injury
by Robert F. Kennedy, Jr.
Too many "deaths by coincidence" among recipients of C-vax
Exactly the same line that doctors have long handed parents whose children died, or fell ill, then never were the same, after their shots.
01/14/21 BIG PHARMA › VIEWS
Death by Coincidence?
Declarations by health officials and vaccine makers that deaths and injuries following COVID vaccinations are unrelated coincidences are becoming a pattern. They’re also depriving people of the information they need to make informed decisions.
The official handling last week of the deaths of two Danes and a Miami doctor following their COVID jabs highlights the gaping holes in the government’s surveillance system for detecting post-marketing vaccine reactions.
These incidents suggest that health officials will be unlikely to give the public authentic risk profiles for the emergency use COVID vaccines.
Accurate risk profiles allow regulators to determine if a medical intervention is causing more harm than good and consumers to make rational choices about their own use of a product.
Regulators usually develop risk assessments during preclinical trials by comparing health outcomes in individuals receiving the intervention against a placebo group. Such studies must be large enough to detect rare injuries and of sufficient duration to reveal ailments with long diagnosis horizons.
Click on the link for the rest.